Skip to content

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

Nufarm shares skyrocket 34% as $1.18b sales agreement is announced

Though Nufarm announced that it would not pay a dividend in FY19, the company revealed good revenue and earnings (EBITDA) growth when it released its full-year results today.

Nufarm share price soar on FY19 results Source: Bloomberg

During the morning session the Nufarm (ASX: NUF) share price soared as much as 34%, following the release of solid FY19 results and the announcement of plans to sell its Nufarm South America business for A$1.18 billion.

By the afternoon session, bullish action around the stock had moderated somewhat, with the Nufarm share price trading around the A$5.60 mark.

Some market commentators have suggested that a ‘short squeeze’ was a likely contributor to today’s bullish price action; given that around 17% of Nufarm’s stock was held short prior to today’s announcement.

Nufarm share price: 2019 results in focus

On the top-line, Nufarm (ASX: NUF) posted FY19 revenue of A$3,758 million – up 14% from the year prior. With the company noting that it saw revenue growth in all regions, bar Australia and New Zealand.

On the bottom-line, company earnings (EBITDA) also got a modest boost – rising 9% to A$420 million.

As the company pointed out, this was ‘driven by a full year contribution from the European portfolio acquisitions and growth in the North America, Seed Technologies and Asia business segments.’

Overall however, Nufarm’s NPAT came in 9% lower than it did in 2018.

Even so, the company has seen its balance sheet strengthened as a result of the equity raise it completed earlier this year; with the company reducing its net debt 9% to A$1,247 million.

Nufarm additionally noted that it has suspended its FY19 dividend ‘while the company focuses on deleveraging the balance sheet.’

Nufarm South American sale

Financial performance aside, the headline news of today's FY19 results relates to the proposed sale of Nufarm South America’s crop protection and seed treatment businesses, to Sumitomo Chemical Company, for a sum of A$1,188 million.

As part of the proposed sale, the companies 'will enter into a two year supply agreement and transitional services agreement under which Nufarm will provide procurement services and continued supply of certain productions to the South American businesses.’

Though the sale has been unanimously recommended by the Board, the company noted that shareholder approval is still required for the sale to be finalised, 'under Chapter 10 of the ASX Listing Rules, regulatory approvals and satisfaction of other conditions precedent.’

Nufarm is aiming to have the transaction completed by the first-half of the 2020 fiscal year.

Even with today’s sharp upwards price action Nufarm’s (ASX: NUF) share price has traded mostly flat for the year, rising just 4% since January.

This information has been prepared by IG, a trading name of IG Markets Ltd and IG Markets South Africa Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.